查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413142

下一代肿瘤设备和解决方案市场：按组成部分、癌症类型和最终用户 - 2024-2030 年全球预测

Next-Generation Oncology Devices & Solutions Market by Component (Devices, Software), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

下一代肿瘤设备和解决方案市场规模预计到2023年为156.2亿美元，2024年达到189.7亿美元，预计到2030年将达到598.4亿美元，复合年增长率为21.15%。

下一代肿瘤设备和解决方案的全球市场

主要市场统计
基准年[2023] 156.2亿美元
预测年份 [2024] 189.7亿美元
预测年份 [2030] 598.4亿美元
复合年增长率（%） 21.15%
下一代肿瘤设备和解决方案市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估下一代肿瘤设备和解决方案市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对下一代肿瘤设备和解决方案市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-下一代肿瘤设备和解决方案市场的市场规模和预测是多少？

2-在下一代肿瘤设备和解决方案市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3-下一代肿瘤设备和解决方案市场的技术趋势和法律规范是什么？

4-下一代肿瘤设备和解决方案市场主要供应商的市场占有率是多少？

5-进入下一代肿瘤设备和解决方案市场的适当型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率增加
      • 人们对微创诊断和治疗技术的兴趣日益浓厚
      • 政府努力改善医疗基础设施
    • 抑制因素
      • 製造下一代设备需要大量初始投资
    • 机会
      • 肿瘤检测和治疗领域的技术不断进步
      • 个体化和先进基因组医学的普及
    • 任务
      • 对诊断标准化不足的担忧
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章下一代肿瘤设备和解决方案市场：按组成部分

  • 装置
    • 先进的放射治疗
    • 高强度聚焦超音波
  • 软体

第 7 章按癌症类型分類的下一代肿瘤设备和解决方案市场

  • 乳癌
  • 子宫颈癌
  • 大肠直肠癌
  • 肺癌

第 8 章下一代肿瘤设备和解决方案市场：按最终用户分类

  • 影像诊断中心
  • 医院

第 9 章美洲下一代肿瘤设备与解决方案市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区下一代肿瘤设备和解决方案市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的下一代肿瘤设备和解决方案市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Brainlab
    • Danaher Corporation
    • Exact Sciences Corp.
    • F. Hoffmann-La Roche Ltd.
    • GE HealthCare Technologies, Inc.
    • Guardant Health Inc.
    • Hologic, Inc.
    • Illumina, Inc.
    • Johnson & Johnson Services Inc.
    • Merck & Co., Inc.
    • Myriad Genetics, Inc.
    • NanoString Technologies, Inc.
    • Natera, Inc.
    • NeoGenomics, Inc.
    • Novartis AG
    • Paige.AI, Inc.
    • PerkinElmer, Inc.
    • QIAGEN NV
    • Quest Diagnostics Incorporated
    • Royal Philips
    • Siemens AG
    • Sysmex Corporation
    • Takara Bio USA, Inc.
    • Thermo Fisher Scientific Inc.
    • Veracyte, Inc.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-2E76C3E47F82

[186 Pages Report] The Next-Generation Oncology Devices & Solutions Market size was estimated at USD 15.62 billion in 2023 and expected to reach USD 18.97 billion in 2024, at a CAGR 21.15% to reach USD 59.84 billion by 2030.

Global Next-Generation Oncology Devices & Solutions Market

KEY MARKET STATISTICS
Base Year [2023] USD 15.62 billion
Estimated Year [2024] USD 18.97 billion
Forecast Year [2030] USD 59.84 billion
CAGR (%) 21.15%
Next-Generation Oncology Devices & Solutions Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation Oncology Devices & Solutions Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation Oncology Devices & Solutions Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Oncology Devices & Solutions Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Brainlab, Danaher Corporation, Exact Sciences Corp., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Guardant Health Inc., Hologic, Inc., Illumina, Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Natera, Inc., NeoGenomics, Inc., Novartis AG, Paige.AI, Inc., PerkinElmer, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Royal Philips, Siemens AG, Sysmex Corporation, Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Veracyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Oncology Devices & Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Devices
      • Advanced Forms of Radiation Therapy
      • High-Intensity Focused Ultrasound
    • Software
  • Cancer Type
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • Lung Cancer
  • End User
    • Diagnostic Imaging Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Next-Generation Oncology Devices & Solutions Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation Oncology Devices & Solutions Market?

3. What are the technology trends and regulatory frameworks in the Next-Generation Oncology Devices & Solutions Market?

4. What is the market share of the leading vendors in the Next-Generation Oncology Devices & Solutions Market?

5. Which modes and strategic moves are suitable for entering the Next-Generation Oncology Devices & Solutions Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Next-Generation Oncology Devices & Solutions Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cancer across the globe
      • 5.1.1.2. Rising preference for minimally invasive techniques of diagnosis and treatment
      • 5.1.1.3. Government Initiatives to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investments for manufacturing of next generation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements oncology testing and treatment
      • 5.1.3.2. Proliferation of personalized and advanced genome medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concern associated with the insufficient standardization of diagnostics
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Next-Generation Oncology Devices & Solutions Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
    • 6.3.1. Advanced Forms of Radiation Therapy
    • 6.3.2. High-Intensity Focused Ultrasound
  • 6.3. Software

7. Next-Generation Oncology Devices & Solutions Market, by Cancer Type

  • 7.1. Introduction
  • 7.2. Breast Cancer
  • 7.3. Cervical Cancer
  • 7.4. Colorectal Cancer
  • 7.5. Lung Cancer

8. Next-Generation Oncology Devices & Solutions Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Imaging Centers
  • 8.3. Hospitals

9. Americas Next-Generation Oncology Devices & Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation Oncology Devices & Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation Oncology Devices & Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Agilent Technologies, Inc.
    • 13.1.3. Bio-Rad Laboratories, Inc.
    • 13.1.4. Brainlab
    • 13.1.5. Danaher Corporation
    • 13.1.6. Exact Sciences Corp.
    • 13.1.7. F. Hoffmann-La Roche Ltd.
    • 13.1.8. GE HealthCare Technologies, Inc.
    • 13.1.9. Guardant Health Inc.
    • 13.1.10. Hologic, Inc.
    • 13.1.11. Illumina, Inc.
    • 13.1.12. Johnson & Johnson Services Inc.
    • 13.1.13. Merck & Co., Inc.
    • 13.1.14. Myriad Genetics, Inc.
    • 13.1.15. NanoString Technologies, Inc.
    • 13.1.16. Natera, Inc.
    • 13.1.17. NeoGenomics, Inc.
    • 13.1.18. Novartis AG
    • 13.1.19. Paige.AI, Inc.
    • 13.1.20. PerkinElmer, Inc.
    • 13.1.21. QIAGEN N.V.
    • 13.1.22. Quest Diagnostics Incorporated
    • 13.1.23. Royal Philips
    • 13.1.24. Siemens AG
    • 13.1.25. Sysmex Corporation
    • 13.1.26. Takara Bio USA, Inc.
    • 13.1.27. Thermo Fisher Scientific Inc.
    • 13.1.28. Veracyte, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET DYNAMICS
  • FIGURE 7. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
  • FIGURE 10. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 8. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ADVANCED FORMS OF RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 188. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET LICENSE & PRICING